We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Adel - Cost Analysis of Using Plerixafor Plus G-CSF Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma Patients Treated At Memorial Sloan-Kettering Cancer Center (MSKCC)
Nelly G. Adel, PharmD, BCOP, BCPS
Memorial Sloan-Kettering Cancer Center
New York, New York, USA
12.01.11


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles